Amendment to Securities Report - 21st Period (2025/04/01 - 2026/03/31)

Daiichi Sankyo Company Amendment to Securities Report - 21st Period (2025/04/01 - 2026/03/31)

Daiichi Sankyo Company has amended the securities report for the 21st period (April 1, 2025 - March 31, 2026). This amendment was made to ensure the accuracy of financial information.

Daiichi Sankyo Company is primarily engaged in the development, manufacturing, and sales of pharmaceuticals. This amendment is important information for investors and stakeholders.

This amendment improves the transparency of financial information and provides information that serves as a reference for investment decisions.